ICER Can Do Better for Patients.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31039068.
- Also identified by DOI 10.18553/jmcp.2019.25.5.514 and PMC identifier 10397836.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No outside funding supported the writing of this article. Mendez is president and CEO of the Asthma and Allergy Foundation of America, which receives greater than 25% of its funding to produce educational materials and for patient research through grants from pharmaceutical companies, including AstraZeneca, Genentech, GSK, Sanofi/Regeneron, and Teva.
Medical subject headings
- Anti-Asthmatic Agents
- Asthma
- Cost-Benefit Analysis
- Data Interpretation, Statistical
- Models, Economic